Literature DB >> 19181455

AMP-activated kinase may suppress NADPH oxidase activation in vascular tissues.

Mark F McCarty1, Jorge Barroso-Aranda, Francisco Contreras.   

Abstract

Activation of AMP-activated kinase (AMPK) suppresses NF-kappaB-mediated transcription in endothelial cells exposed to palmitate or TNF-alpha; it also impedes angiotensin II-driven proliferation in vascular smooth muscle cells. These phenomena become predictable if we postulate that AMPK can inhibit activation of NADPH oxidase. Such an effect would make sense from a homeostatic perspective, and moreover there is direct evidence that AMPK suppresses NADPH oxidase activation in neutrophils. New evidence that sub-pathological levels of peroxynitrite can activate AMPK suggest that this enzyme may act as an "early warning signal" for oxidant stress; inhibiting NADPH oxidase would constitute a rational feedback response to such a signal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181455     DOI: 10.1016/j.mehy.2008.12.024

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  9 in total

1.  Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway.

Authors:  Ting He; Jiachuan Xiong; Ling Nie; Yanlin Yu; Xu Guan; Xinli Xu; Tangli Xiao; Ke Yang; Liang Liu; Daohai Zhang; Yunjian Huang; Jingbo Zhang; Junping Wang; Kumar Sharma; Jinghong Zhao
Journal:  J Mol Med (Berl)       Date:  2016-08-04       Impact factor: 4.599

Review 2.  Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems.

Authors:  Ping Song; Ming-Hui Zou
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

Review 3.  Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?

Authors:  Yves Gorin; Karen Block
Journal:  Free Radic Biol Med       Date:  2013-03-23       Impact factor: 7.376

Review 4.  AMPK activation--protean potential for boosting healthspan.

Authors:  Mark F McCarty
Journal:  Age (Dordr)       Date:  2013-11-19

5.  Nox4 mediates renal cell carcinoma cell invasion through hypoxia-induced interleukin 6- and 8- production.

Authors:  John P Fitzgerald; Bijaya Nayak; Karthigayan Shanmugasundaram; William Friedrichs; Sunil Sudarshan; Assaad A Eid; Thomas DeNapoli; Dipen J Parekh; Yves Gorin; Karen Block
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

Review 6.  Interplay Between Reactive Oxygen/Reactive Nitrogen Species and Metabolism in Vascular Biology and Disease.

Authors:  Masuko Ushio-Fukai; Dipankar Ash; Sheela Nagarkoti; Eric J Belin de Chantemèle; David J R Fulton; Tohru Fukai
Journal:  Antioxid Redox Signal       Date:  2021-06-01       Impact factor: 7.468

Review 7.  Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease.

Authors:  Yves Gorin; Fabien Wauquier
Journal:  Mol Cells       Date:  2015-03-31       Impact factor: 5.034

8.  Potent Inhibitory Effect of BJ-3105, a 6-Alkoxypyridin-3-ol Derivative, on Murine Colitis Is Mediated by Activating AMPK and Inhibiting NOX.

Authors:  Pallavi Gurung; Sadan Dahal; Prakash Chaudhary; Diwakar Guragain; Ujjwala Karmacharya; Jung-Ae Kim; Byeong-Seon Jeong
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

Review 9.  AMPK, Mitochondrial Function, and Cardiovascular Disease.

Authors:  Shengnan Wu; Ming-Hui Zou
Journal:  Int J Mol Sci       Date:  2020-07-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.